Your browser doesn't support javascript.
loading
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials.
Koster, Bas D; van den Hout, Mari F C M; Sluijter, Berbel J R; Molenkamp, Barbara G; Vuylsteke, Ronald J C L M; Baars, Arnold; van Leeuwen, Paul A M; Scheper, Rik J; Petrousjka van den Tol, M; van den Eertwegh, Alfons J M; de Gruijl, Tanja D.
Afiliación
  • Koster BD; Department of Medical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van den Hout MFCM; Department of Pathology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Sluijter BJR; Department of Surgical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Molenkamp BG; Department of Surgical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Vuylsteke RJCLM; Department of Surgical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Baars A; Department of Pathology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van Leeuwen PAM; Department of Surgical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Scheper RJ; Department of Pathology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Petrousjka van den Tol M; Department of Surgical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van den Eertwegh AJM; Department of Medical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • de Gruijl TD; Department of Medical Oncology, VU University Medical Center - Cancer Center Amsterdam, Amsterdam, the Netherlands. td.degruijl@vumc.nl.
Clin Cancer Res ; 23(19): 5679-5686, 2017 Oct 01.
Article en En | MEDLINE | ID: mdl-28972083
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligodesoxirribonucleótidos / Oligonucleótidos / Melanoma / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligodesoxirribonucleótidos / Oligonucleótidos / Melanoma / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos